HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hisanori Shinohara Selected Research

Sarcopenia

12/2020Impact of sarcopenia on glycemic control and atherosclerosis in Japanese patients with type 2 diabetes: Cross-sectional study using outpatient clinical data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hisanori Shinohara Research Topics

Disease

5AIDS-Related Complex (ARC)
12/2017 - 01/2001
3Carcinogenesis
02/2015 - 12/2011
3Myocardial Infarction
01/2004 - 11/2002
2Atherosclerosis
12/2020 - 01/2004
2Hypertension (High Blood Pressure)
12/2020 - 01/2004
2Hypercholesterolemia
03/2008 - 08/2004
2Ventricular Remodeling
04/2004 - 11/2002
2Heart Failure
04/2004 - 12/2002
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2004 - 10/2002
2Stable Angina
01/2004 - 08/2003
1Sarcopenia
12/2020
1Type 2 Diabetes Mellitus (MODY)
12/2020
1Dyslipidemias (Dyslipidemia)
12/2020
1Photosensitivity Disorders (Photodermatitis)
12/2017
1Neoplasms (Cancer)
07/2017
1Inflammation (Inflammations)
02/2015
1Malignant Mesothelioma
09/2013
1Mesothelioma
12/2011
1Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
11/2006
1Atrioventricular Nodal Reentry Tachycardia (AV Nodal Reentrant Tachycardia)
06/2004
1Persistent Left Superior Vena Cava
06/2004
1Diabetes Mellitus
01/2004
1Coronary Disease (Coronary Heart Disease)
01/2004
1Coronary Stenosis (Coronary Artery Stenosis)
01/2004
1Unstable Angina
08/2003
1Acute Coronary Syndrome
08/2003
1Pathologic Constriction (Stenosis)
05/2003
1Cardiac Sudden Death (Sudden Cardiac Arrest)
10/2002
1Cardiovascular Diseases (Cardiovascular Disease)
10/2002

Drug/Important Bio-Agent (IBA)

2FullerenesIBA
12/2017 - 12/2002
2SootIBA
03/2014 - 12/2002
2Carbon Nanotubes (Carbon Nanotube)IBA
09/2013 - 12/2011
2AsbestosIBA
09/2013 - 12/2011
2Atorvastatin (Lipitor)FDA Link
03/2008 - 08/2004
2LipidsIBA
08/2004 - 01/2004
2Angiotensin Receptor AntagonistsIBA
04/2004 - 12/2002
2Cell Adhesion MoleculesIBA
01/2004 - 08/2003
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2020
1Biomarkers (Surrogate Marker)IBA
12/2020
1Polytetrafluoroethylene (Teflon)FDA Link
12/2017
1Singlet OxygenIBA
12/2017
1SolventsIBA
11/2017
1Contrast MediaIBA
07/2017
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
03/2014
1CarcinogensIBA
09/2013
1MetalsIBA
11/2006
1TerbiumIBA
11/2006
1LDL Lipoproteins (beta Lipoproteins)IBA
08/2004
1Plasminogen InactivatorsIBA
08/2004
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
04/2004
1cadherin 5IBA
01/2004
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2003
1Platelet Endothelial Cell Adhesion Molecule-1IBA
08/2003
1P-SelectinIBA
08/2003
1Brain Natriuretic Peptide (Natrecor)FDA Link
05/2003
1DysprosiumIBA
12/2002
13-Iodobenzylguanidine (Iobenguane)IBA
12/2002
1Angiotensin IIIBA
12/2002
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
11/2002
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2002
1Plasminogen Activator Inhibitor 1IBA
10/2002
1Tissue Plasminogen Activator (Alteplase)FDA Link
10/2002
1C-Reactive ProteinIBA
10/2002
1Plasminogen Activators (Plasminogen Activator)IBA
10/2002
1PowdersIBA
01/2001
1GraphiteIBA
01/2001

Therapy/Procedure

2Therapeutics
08/2004 - 04/2004
1Glycemic Control
12/2020
1Intraperitoneal Injections
02/2015
1Catheter Ablation
06/2004
1Synchrotrons
01/2001